Baduanjin · Systematic review

Baduanjin Benefits: What the 2017 Review Actually Found

Explore a review of 19 Baduanjin trials. See what sleep and quality-of-life scores measured, how the programmes differed, and why results have limits.

The short answer

Pooled sleep and quality-of-life scores favoured Baduanjin, but participants, programmes and comparison groups differed. The results do not predict extra hours of sleep, a personal percentage improvement or lasting effects over years.

Study and source overview

Can this review tell me whether Baduanjin will improve my sleep or quality of life?

Review scope
The 2017 systematic review included 19 randomised trials and 1,535 adults, including healthy participants and people with several health conditions.
Outcome samples
Sleep: six trials, 597 participants. Quality of life: six trials, 611 participants. Neither estimate used all 1,535 participants.
Programmes and comparisons
Programmes lasted 4–24 weeks, with different schedules, supervision and usual care. Comparisons included usual lifestyle, health education, usual care and walking.
Source coverage
Relevant sections of the accessible full text, including trial tables, sleep and quality-of-life analyses and limitations. This is a historical review, not all current evidence.

What did sleep and quality-of-life scores measure?

Sleep studies used questionnaires such as the Pittsburgh Sleep Quality Index (PSQI). Quality-of-life studies used different general or condition-specific questionnaires. These reflect reported experiences; they do not establish that insomnia was cured, medication use fell or people slept a particular number of extra hours.

OutcomePooled resultHow to read it
Sleep qualitySix trials, 597 participants; standardised mean difference −0.55, 95% confidence interval −0.97 to −0.12.The direction favoured Baduanjin. This is not a 0.55-point PSQI change or a 55% improvement.
Quality of lifeSix trials, 611 participants; standardised mean difference −0.75, 95% confidence interval −1.26 to −0.24.The direction favoured Baduanjin, across different scales and populations. It does not mean everyone improved by 75%.

A standardised mean difference puts different scales onto a common scale for pooling. It no longer has the original units, such as points or hours. These estimates alone cannot tell a reader how noticeable a change would feel. The intervals describe uncertainty in the estimated average effect, not the range of improvement for each participant.

Why is there no single expectation for beginners?

Healthy students, older adults and participants with diabetes or other conditions started in different circumstances. Some trials added Baduanjin to existing care; others compared it with no new activity. The pooled result does not establish superiority over every other exercise.

Participants knew which activity they were doing, so expectations may have influenced self-reported outcomes. Some studies did not include people who dropped out in their analysis. Dropout may relate to burden or outcomes. There are also inconsistencies between some trial-table details and citations, limiting precise predictions for particular groups.

This summary keeps the sleep and quality-of-life estimates separate. It does not turn other outcomes, such as blood pressure or balance, into a list of benefits promised to everyone. A particular health question needs its own evidence.

What does it tell us about time and safety?

The trial schedules differed substantially. One study in healthy students used five 60-minute sessions a week for 12 weeks. Another study in people with chronic conditions used two weekly 30–40-minute sessions plus home practice and compared the programme with walking. These are study conditions, not a standard dose for beginners.

There was little follow-up beyond the courses. Results over 4–24 weeks cannot establish benefits over years. Only two entries explicitly reported no adverse events; most did not mention them. An absence of reporting does not establish that active monitoring found no problems.

Where can I read more about sleep?

The 12-week Baduanjin sleep trial provides a more specific example, with eligibility criteria, measurement times and gaps in the abstract. Do not count a review and a trial it includes as independent samples.

For the difference between a course and later follow-up, read research timeframes. Neither this review nor a single questionnaire score can assess the cause of a reader's ongoing sleep problems.

Original source and review coverage

Zou L et al. A Systematic Review and Meta-Analysis Baduanjin Qigong for Health Benefits: Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine. 2017;2017:4548706.

DOI:10.1155/2017/4548706

Open the original source ↗

Review coverage: Relevant sections of the full text accessed through the official Europe PMC XML copy: Tables 1–2, sleep and quality-of-life analyses, Figures 2–3 and limitations. We did not reanalyse individual trial data. The PMC browser page displayed a verification challenge.

Cochrane Handbook, Chapter 15: Interpreting results:Explains standardised mean differences, confidence intervals and practical importance. It does not add trial participants to the Baduanjin review. The current chapter and training-site alternative returned HTTP 403 during the English source check; the current text was not verified.

By First Chi; source checked .The paper was published in 2017; the website update date does not replace that date.

First Chi

Learn the steps. Follow the cues. Keep a record.